CCL3 and neoplasm: The more recent preclinical study by Allen et al. [52] supports the work by Song et al. [50] demonstrating that autologous tumor-derived CCL3 enhances IFNγ production and promotes dendritic cell maturation within tumor-draining lymph nodes (TDLN) in a CCL3-dependent manner.